YPSOMED is a Swiss based developer and manufacturer of self-injection devices with nearly 40 years of experience and numerous high precision and high quality devices on the global market.
Ypsomed provides a complete range of technologies and services for reliable and user-friendly self-injection systems for injectables such as insulin, GLP-1, hGH and mAbs. Our customers are pharmaceutical and biotechnology companies worldwide that develop, manufacture and market medications for self-injection.
more >
Year of Establishment:
1984
Total Number of Staff:
more than 500
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: